ChoKs as a promising therapeutic target for a variety of pathologies
DOI:
https://doi.org/10.31989/bchd.v4i11.859Abstract
Alterations in cell metabolism represent a common cause of human diseases. Changes in lipid profiles are not an exception to this rule, including those lipids that are produced via the choline kinase (ChoK) pathway. ChoK catalyzes the conversion of choline to phosphocholine via the transfer of a phosphate group from ATP to choline . The formation of phosphocholine is the first step in the Kennedy pathway, which is responsible for the generation of phosphatidylcholine, a critical cell membrane component. ChoK functions as a mediator of cell growth and division and is upregulated in many types of cancers including breast cancer, pancreatic ductal adenocarcinoma, and others. A number of inhibitors have been developed that can block the activity of human ChoK (hChoK) and other eukaryotic
ChoKs, such as those found in parasites. Therefore, ChoK inhibitors (ChoKIs) are promising therapeutics, not only
for cancer [4], but for malaria and other diseases caused by parasites. This family of inhibitors are also promising therapeutics for autoimmune diseases such as rheumatoid arthritis and inflammatory conditions.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 FFC/Bioactive Compounds in Health and Disease
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License.
This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged.
By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained.